Announcing our $19,8 million Series A round. Read more here.

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

Idoven's AI platform, a key ally for ICMs to improve arrhythmia and false positive detection.

Jose María Lillo Castellano

AstraZeneca and Idoven are using Artificial Intelligence to diagnose cardiovascular diseases through a pioneering project in Europe

#WorldHeartDay - An interview with María de la Parte, Pediatric cardiologist at Idoven

September is atrial fibrillation awareness month

Raquel Toribio Fernández

Blog

1

5

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022

Idoven's AI platform, a key ally for ICMs to improve arrhythmia and false positive detection.

Idoven's AI platform improves arrhythmia and false positive detection on ICM Confirm RxTM Abbott

AstraZeneca and Idoven are using Artificial Intelligence to diagnose cardiovascular diseases through a pioneering project in Europe

AstraZeneca and Idoven are using Artificial Intelligence to diagnose heart failure through a pioneering project in Europe

September is atrial fibrillation awareness month

Atrial fibrillation, an increasing epidemic

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022

Science & Technology

CB Insights has named Idoven as one of the 150 most promising private digital health companies of 2022.

Idoven's AI platform improves arrhythmia and false positive detection on ICM Confirm RxTM Abbott

Science & Technology

Idoven's AI platform, a key ally for ICMs to improve arrhythmia and false positive detection.

AstraZeneca and Idoven are using Artificial Intelligence to diagnose heart failure through a pioneering project in Europe

AstraZeneca and Idoven are using Artificial Intelligence to diagnose cardiovascular diseases through a pioneering project in Europe

#WorldHeartDay - An interview with María de la Parte, Pediatric cardiologist at Idoven

#WorldHeartDay - An interview with María de la Parte, Pediatric cardiologist at Idoven

Atrial fibrillation, an increasing epidemic

September is atrial fibrillation awareness month

Idoven health-tech startups selected of the #EdisonAccelerator by GE Healthcare

[VIDEO] Idoven, one of the 7 health-tech startups selected for the #EdisonAccelerator by GE Healthcare